Biomed & Biotech Firms - Publicly Traded*

Regulus Therapeutics Inc.

Company Website

3545 John Hopkins Ct. Ste., 210
San Diego, CA 92121

Sourcebook Data

View all the companies in Biomed & Biotech Firms - Publicly Traded*

Regulus Therapeutics Inc.

Market Cap as of 6/12/2015

$505,072,320

Market Cap as of 7/03/2014

$351,623,826

Market Cap as of 07/02/2013

$372,855,347

Market Cap as of 06/26/2012

Market Cap as of 01/04/2012

Market Cap as of 06/20/2011

Market Cap as of 01/06/2011

Exchange and Ticker Symbol

Nasdaq: RGLS

Fields of Research

Major Products

Executives

Kleanthis Xanthopoulos (profile)

  • Chief Executive Officer
  • President